This compound is a pharmaceutical intermediate used in the synthesis of exatecan, a topoisomerase I inhibitor. It features an amide group, an aromatic ring, and a halogen atom.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
3-(4-piperidyl)propanoic acid
pharmaceutical intermediate
4-(Chloromethyl)pyridine hydrochloride
pharmaceutical intermediate
4-Cbz-Aminopiperidine
pharmaceutical intermediate
4-(2-Tetrahydropyranyloxy)phenylboronic acid
pharmaceutical intermediate
7-Methyl-1-tetralone
Chemical intermediate
7-Hydroxy-1-tetralone
pharmaceutical intermediate
6-methoxy-2-methyl-3,4-dihydro-2H-naphthalen-1-one
pharmaceutical intermediate
Levobunolol hydrochloride
pharmaceutical raw material
N-(8-amino-6-fluoro-5-methyl-1-oxo-3,4-dihydro-2H-naphthalen-2-yl)acetamide
SEFPQWAVZCZXTK-UHFFFAOYSA-N
CC1=C(C=C(C2=C1CCC(C2=O)NC(=O)C)N)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.